MedPath

A study comparing Unani medicine and Autologous Serum Therapy for treating chronic urticaria

Phase 2
Conditions
Health Condition 1: L509- Urticaria, unspecified
Registration Number
CTRI/2024/07/071481
Lead Sponsor
Department of Amraze Jild wa Zohrawiya Ajmal Khan Tibbiya College and Hospital AMU Aligarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

• Clinically diagnosed patients of Chronic Urticaria (Urticaria of more than 6 weeks); with clinical features of erythema, itching and wheals of any grade.

• Patients of either sex in the age group of 18 years onwards.

• Patients who have agreed to sign the written informed consent and follow the protocol.

Exclusion Criteria

• Patients with other skin diseases like psoriasis, eczema, etc. by history and examination.

• Patients of urticaria presenting with features of angioedema.

• Patients suffering from any other systemic diseases, such as HTN, DM, IHD, HIV, and bronchial asthma will be excluded on the basis of history and examination.

• Pregnant and lactating women.

• Patient already taking modern medicine or will be included in the study after a washout period of 2 weeks.

• In case of worsening of the symptoms, the patient will be shifted to the standard management.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath